Vir Bio (VIR) reveals 24-week post-end-of-treatment data from a mid-stage trial for its Hep B therapy developed with Xencor ...

The "Hepatitis B - Pipeline Insight, 2025" drug pipelines has been added to ResearchAndMarkets.com's offering.This report outlays comprehensive insights of present clinical development scenario and ...

Vir Biotechnology’s sidelined hepatitis B candidate, designed to serve as a “functional cure,” has failed to achieve the ...

Vir Biotechnology, Inc. progresses HDV treatment with promising ECLIPSE program results. Click here to find out why VIR stock ...

Patients attending Medway Maritime Hospital's A&E will now be routinely tested for HIV and hepatitis unless they opt out. The ...

Understanding how to prevent Hepatitis is key to maintaining liver health and protecting communities. Let’s break it down ...

Liver disease patients are falling through the cracks and not getting the treatment they need. Support from people with lived ...

A common medication used to treat HIV and hepatitis B may offer unexpected protection against Alzheimer's disease.

Drug companies—and innovation—will suffer thanks to Trump’s executive order.

Despite these figures, Tibinyane highlighted significant progress in the national HIV response. Since 2010, Namibia has witnessed a 54% decline in new HIV infections and a 33% reduction in ...